文献速递主动脉疾病外周动脉疾病慢性静脉疾病

血管手术患者静脉血栓栓塞预防的荟萃分析与系统评价

A meta-analysis and systematic review of venous thromboembolism prophylaxis in patients undergoing vascular surgery procedures.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-04-21

该系统评价检索了MEDLINE、Cochrane和Embase数据库,纳入42篇关于血管手术患者VTE预防的研究。荟萃分析(5项研究)显示VTE预防组相对风险为0.70(95%CI 0.26-1.87),无统计学显著获益,但预防组VTE发生率较低。临床应使用风险预测模型识别高危患者并个体化预防。

要点

  • 血管手术VTE预防的总体证据有限,荟萃分析未显示统计学显著获益。
  • 开放主动脉重建后VTE风险为13%~18%,预防未降低该风险。
  • 应使用VTE风险预测模型识别高危患者,个体化决定预防策略。

核心结论

  • 血管手术患者VTE预防的文献匮乏,荟萃分析未显示统计学显著获益,但预防组VTE发生率较低。
  • 临床应识别VTE高危患者,风险-获益比可能支持选择性患者接受预防。

研究设计与样本

  • 从3757篇文献中纳入42篇出版物,其中5项研究进入荟萃分析。

主要发现

  • 荟萃分析显示VTE预防组发生VTE的相对风险为0.70(95%CI 0.26-1.87)。
  • 开放主动脉重建后VTE风险为13%~18%,且不被VTE预防降低。
  • EVAR患者未预防时VTE风险为6%。
  • 外周旁路手术未接受治疗性或预防性抗凝者VTE风险<2%。
  • 截肢患者VTE预防可降低VTE风险;浅静脉疾病手术文献证据矛盾。

关键数值与推荐

  • 开放主动脉重建后VTE风险13%~18%,预防未降低。
  • EVAR未预防VTE风险6%。
  • 外周旁路未抗凝VTE风险<2%。
  • VTE预防相对风险0.70(95%CI 0.26-1.87)。

临床怎么用

  • 临床医生应使用判断和已建立的VTE风险预测模型评估患者VTE风险。
  • 识别VTE高危患者,风险-获益比可能支持选择性患者接受VTE预防。
  • 血管外科医生应考虑将VTE发生率作为次要结局报告。

局限性

  • 血管手术患者VTE预防的文献总体匮乏。
  • 荟萃分析仅纳入5项研究,证据有限。
  • 浅静脉疾病手术的VTE预防证据存在矛盾。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Perioperative venous thromboembolism (VTE) is generally considered preventable. Whereas the non-vascular surgery literature is rich in providing data about the impact of VTE prophylaxis on VTE outcomes, vascular surgery data are relatively sparse on this topic. This study sought to evaluate the evidence for VTE prophylaxis specifically for the population of vascular surgery patients. METHODS: A systematic search was conducted in MEDLINE, Cochrane, and Embase databases in December 2018. Included were studies reporting primary and secondary outcomes for common vascular surgery procedures (open aortic operation, endovascular aneurysm repair [EVAR], peripheral artery bypass, amputation, venous reflux operation). A meta-analysis was performed comparing the patients who did not receive VTE prophylaxis and had VTE complications with patients who developed VTE despite receiving prophylaxis. RESULTS: From 3757 uniquely identified articles, 42 publications met the criteria for inclusion in this review (1 for the category of all vascular operations, 5 for open aortic reconstructions, 2 for EVAR, 1 for open aortic surgery or EVAR, 3 for abdominal or bypass surgery, 2 for peripheral bypass surgery, 2 for amputations, 1 for vascular trauma, and 25 for surgical treatment of superficial venous disease). Five studies met the criteria for inclusion in the meta-analysis. The results demonstrated slightly lower relative risk for development of VTE among patients receiving VTE prophylaxis (relative risk, 0.70; 95% confidence interval, 0.26-1.87). After open aortic reconstruction, the risk of VTE is 13% to 18% and is not reduced by VTE prophylaxis. For EVAR patients, the risk of VTE without prophylaxis is 6%. For patients undergoing peripheral bypass surgery and not receiving therapeutic or prophylactic anticoagulation, the risk of VTE is <2%. For patients undergoing amputations, VTE prophylaxis reduces the risk of VTE. For patients undergoing surgical treatment of superficial venous disease, there is an abundance of literature exploring the utility of VTE prophylaxis, but the evidence is conflicting; some studies demonstrated a benefit, whereas others showed no reduction of VTE with prophylaxis. CONCLUSIONS: Overall, there is a paucity of literature that addresses the effectiveness of VTE prophylaxis specifically in the population of vascular surgery patients. Our meta-analysis of the literature does not demonstrate a statistically significant benefit of VTE prophylaxis among the vascular surgery patients evaluated; however, it does suggest a low incidence of VTE among patients who receive VTE prophylaxis. Clinicians should identify the patients at high risk for development of postoperative VTE as the risk-benefit ratio may favor VTE prophylaxis in a selected group of patients. Clinicians should use their judgment and established VTE risk prediction models to assess VTE risk for patients. Vascular surgeons should consider reporting VTE incidence as a secondary outcome in publications.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Toth S, Flohr TR, Schubart J, et al. A meta-analysis and systematic review of venous thromboembolism prophylaxis in patients undergoing vascular surgery procedures. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32330639. doi:10.1016/j.jvsv.2020.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。